The parent molecule is a larger protein called BPC (Body Protective Compound) that was first isolated from human gastric juice in the 1990s by a research group at the University of Zagreb
NaBPC157 (administered either in the ng or g/kg range, i.p.) significantly reduced the reactions in the writhing (inflammatory and non-inflammatory, prostaglandin-dependent and independent) and tail pinching tests
For years in physical therapy, we have noticed that patients with this condition usually have hip weakness
By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility [3]
The medication is indicated for weight loss, type 2 diabetes and improving metabolic health in obese and overweight patients with other weight-related health conditions